News

  • 15 April 2014

    Merck obtains FDA approval for grass pollen allergy drug

    Merck has obtained approval from the US Food and Drug Administration (FDA) for its Grastek (Timothy grass pollen allergen extract) sublingual tablet as immunotherapy for treatment of grass pollen-induced allergic...

Go Top